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MaBACKGROUND Little is known about the incidence of and risk factors for sick sinus syndrome (SSS), a common
indication for pacemaker implantation.
OBJECTIVES This study sought to describe the epidemiology of SSS.
METHODS This analysis included 20,572 participants (mean baseline age 59 years, 43% male) in the ARIC
(Atherosclerosis Risk In Communities) study and the CHS (Cardiovascular Health Study), who at baseline were free
of prevalent atrial ﬁbrillation and pacemaker therapy, had a heart rate of $50 beats/min unless using beta blockers,
and were identiﬁed as of white or black race. Incident SSS cases were identiﬁed by hospital discharge International
Classiﬁcation of Disease-revision 9-Clinical Modiﬁcation code 427.81 and validated by medical record review.
RESULTS During an average 17 years of follow-up, 291 incident SSS cases were identiﬁed (unadjusted rate 0.8 per
1,000 person-years). Incidence increased with age (hazard ratio [HR]: 1.73; 95% conﬁdence interval [CI]: 1.47 to
2.05 per 5-year increment), and blacks had a 41% lower risk of SSS than whites (HR: 0.59; 95% CI: 0.37 to 0.98).
Incident SSS was associated with greater baseline body mass index, height, N-terminal pro–B-type natriuretic peptide,
and cystatin C, with longer QRS interval, with lower heart rate, and with prevalent hypertension, right bundle branch
block, and cardiovascular disease. We project that the annual number of new SSS cases in the United States will increase
from 78,000 in 2012 to 172,000 in 2060.
CONCLUSIONS Blacks have a lower risk of SSS than whites, and several cardiovascular risk factors were associated
with incident SSS. With the aging of the population, the number of Americans with SSS will increase dramatically over
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ABBR EV I A T I ON S
AND ACRONYMS
BMI = body mass index
CI = conﬁdence interval
CKD = chronic kidney disease
CRP = C-reactive protein
CV = cardiovascular
ECG = electrocardiogram
HR = hazard ratio
ICD-9-CM = International
Classiﬁcation of Disease-
revision 9-Clinical Modiﬁcation
NT-proBNP = N-terminal pro–
B-type natriuretic peptide
SSS = sick sinus syndrome
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532S ick sinus syndrome (SSS) is a cardiacconduction disorder characterized bysymptomatic dysfunction of the sino-
atrial node. On the electrocardiogram (ECG),
SSS usually manifests as sinus bradycardia,
sinus arrest, or sinoatrial block, and is some-
times accompanied by supraventricular
tachyarrhythmias (“tachy-brady” syndrome).
Typical symptoms of SSS include syncope,
dizziness, palpitations, exertional dyspnea,
easy fatigability from chronotropic incompe-
tence, heart failure, and angina (1–3). Clini-
cally signiﬁcant SSS typically requires pace-
maker implantation. Approximately 30% to
50% of pacemaker implantations in the United
States list SSS as the primary indication (4).SEE PAGE 539Epidemiological information about SSS is limited.
Although past studies have described the characteris-
tics of individuals hospitalized for SSS, the incidence
of SSS in the general population remains unclear.
Additionally, no prior epidemiological studies have
evaluated potential risk factors for incident SSS. The
goals of this analysis were to determine the age and
sex-speciﬁc incidence of SSS in white and black
participants in the ARIC (Atherosclerosis Risk In
Communities) study and the CHS (Cardiovascular
Health Study), as well as to investigate associations
of cardiovascular (CV) risk factors with incident SSS.METHODS
STUDY POPULATION. The prospective cohort ARIC
study comprised 15,792 individuals aged 45 to 64
years of age when recruited between 1987 and 1989
from 4 U.S. communities: Forsyth County, North
Carolina; Jackson, Mississippi (blacks only); Wash-
ington County, Maryland; and the northwestern
suburbs of Minneapolis, Minnesota. The prospective
cohort CHS study consisted of 5,888 community-
dwelling adults age 65 years of age or older from 4
U.S. communities: Forsyth County, North Carolina;
Sacramento County, California; Washington County,
Maryland; and Pittsburgh, Pennsylvania. From 1989
to 1990, CHS recruited 5,201 participants; 687 blacks
were included from 1992 to 1993. The ARIC and CHS
design and recruitment are described in detail else-
where (5–7).
IDENTIFICATION OF INCIDENT SSS. Incident SSSwas
ascertained during cohort follow-up from hospitali-
zation records (8,9). Medical records were reviewed
for hospitalizations that included InternationalClassiﬁcation of Disease-revision 9-Clinical Modiﬁ-
cation (ICD-9-CM) code 427.81 (SSS, sinoatrial node
dysfunction, tachycardia-bradycardia syndrome, per-
sistent sinus bradycardia) in any position. We consid-
ered SSS to be present if the medical record included
a diagnosis of SSS and symptoms or signs consistent
with SSS (e.g., syncope, dizziness, bradycardia, sinus
pauses), with no evidence of other conditions
responsible for the episode, such as atrioventricular
block or medication use.
In the ARIC study, 294 individuals had ICD-9-CM
code 427.81 in at least 1 hospitalization. Of these
participants, we obtained medical records in 195,
from which we conﬁrmed 130 (67%) of the 195 cases
after medical record review. In the CHS study, ICD-
9-CM code 427.81 was present in 179 individuals, and
medical records were available for 169, from which
we conﬁrmed 99 cases (59%) after record review.
To determine the negative predictive value of
ICD-9-CM code 427.81 for SSS, we reviewed medical
records for a random sample of participants with
selected non-SSS ICD-9-CM codes (426.0 and 426.1,
atrioventricular block; 426.6, other heart block;
427.89, other atrial arrhythmia; 37.8, insertion,
placement, and revision of pacemaker; V45.01, status
post-pacemaker implantation; and V53.31, ﬁtting and
adjustment of cardiac pacemaker). Among 178 ARIC
and CHS participants with these selected ICD-9-CM
codes, the medical records documented a diagnosis
of SSS in 5 of them (2.8%), suggesting excellent
negative predictive value for the absence of the
427.81 code.
In the incidence rate calculations, we included
validated SSS cases and a random sample of 63% of
the 109 individuals with ICD-9-CM code 427.81 for
whom medical records were not available. This sam-
pling proportion was based on the positive predictive
value of the ICD-9-CM code 427.81 in those with
available medical records. We included only vali-
dated cases in the risk factor analysis; unvalidated
cases were classiﬁed as noncases.
RISK FACTOR ASCERTAINMENT. Similar methods
were used in the ARIC and CHS studies to assess most
risk factors, as described previously (10,11). Partici-
pants underwent a baseline study examination that
included height and weight measurement, blood
pressure measurement by a random-zero sphygmo-
manometer, and 12-lead resting ECG. Race, smoking,
and alcohol consumption information were deter-
mined by self-report. Information was collected on
medication use, and blood was collected with the
participant in a fasting state, from which glucose,
high-density lipoprotein and low-density lipoprotein
cholesterol, C-reactive protein (CRP), N-terminal
TABLE 1 Baseline Characteristics of Included Participants in ARIC and CHS
ARIC CHS
Whites
(n ¼ 11,226)
Blacks
(n ¼ 4,089)
Whites
(n ¼ 4,427)
Blacks
(n ¼ 830)
Age, yrs 54  5.7 54  5.8 73  6 73  6
Male 47% 37% 42% 36%
High school graduate 83% 59% 73% 54%
BMI, kg/m2 27  4.9 30  6.2 26  4 29  6
Height, cm 169  9.4 168  8.9 165  9 165  9
Systolic blood pressure, mm Hg 119  17 129  22 135  21 143  23
Hypertension 27% 56% 56% 75%
Impaired fasting glucose 38% 34% 14% 12%
Diabetes 9% 20% 14% 26%
HDL-cholesterol, mg/dl 50  17 55  78 54  16 58  15
LDL-cholesterol, mg/dl 138  38 138  43.2 131  35 129  36
C-reactive protein, mg/dl* 4  7 7  7 5  8 6  9
NT-proBNP, ng/l* 211  4,503 224  3,107 242  661 245  1,047
Troponin T, ng/l* 7  10 8  25 8  17 12  53
Cystatin C, mg/l* 0.9  0.3 0.8  0.4 1.1  0.3 1.1  0.3
Heart rate, beats/min 67  10 67  11 65  10 68  11
PR interval, ms 161  26 170  29 170  29 173  30
QRS interval, ms 98  13 97  13 93  17 93  19
Right bundle branch block 0.9% 0.9% 4.2% 5.3%
Left bundle branch block 0.5% 0.4% 1.6% 2.5%
Current smoker 25% 30% 12% 16%
Past smoker 35% 24% 42% 35%
Cigarette pack-yrs 17  22 12  20 36  29 28  26
$1 Alcoholic drink/week 39% 23% 32% 19%
Drinks/week† 3  7 2  7 8  9 8  12
Coronary heart disease 5% 4% 19% 18%
Chronic kidney disease 5% 4% 26% 19%
Heart failure 4% 7% 3% 6%
Stroke 2% 2% 3% 6%
Values are mean  SD or %. *Measured 9 years after baseline in ARIC (Atherosclerosis Risk in Communities)
study. †Among those who reported $1 alcoholic drink per week.
BMI ¼ body mass index; CHS ¼ Cardiovascular Health Study; HDL ¼ high-density lipoprotein; LDL ¼ low-
density lipoprotein; NT-proBNP ¼ N-terminal pro–B-type natriuretic peptide.
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533pro–B-type natriuretic peptide (NT-proBNP),
troponin T, cystatin C, and creatinine levels were
measured (12,13). CRP, NT-proBNP, troponin T, and
cystatin C were measured at baseline in CHS and 9
years after baseline in ARIC. Hypertension was
deﬁned as systolic blood pressure $140 mm Hg,
diastolic blood pressure $90 mm Hg, or use of anti-
hypertensive medications by a participant who re-
ported a physician diagnosis of hypertension.
Diabetes was determined by either a fasting glucose
level of $126 mg/dl or use of an oral hypoglycemic
agent or insulin. Heart rate, PR interval, QRS interval,
and right and left bundle branch block were identi-
ﬁed on study ECGs analyzed at a central ECG labo-
ratory. A history of chronic kidney disease (CKD) and
major CV events, including coronary heart disease,
myocardial infarction, heart failure, and stroke, was
ascertained at baseline study examination (7,14).
Events that occurred during follow-up were identi-
ﬁed from hospitalization records, and ARIC and CHS
study staff and investigators adjudicated these
events (8,9). We deﬁned CKD as an estimated
glomerular ﬁltration rate of <60 ml/min/1.73 m2;
estimated glomerular ﬁltration rate was estimated
from serum creatinine levels (15).
STATISTICAL ANALYSES. Analyses were limited to
white and black participants. Because of their small
numbers, we excluded individuals from other racial/
ethnic groups. Participants who at baseline had
prevalent SSS or atrial ﬁbrillation, a history of pace-
maker implantation, or a heart rate <50 beats/min
while not on beta-blockers also were excluded,
because these conditions often coexist with SSS.
Age-, sex-, and race-speciﬁc SSS incidence rates
were calculated for each age/sex/race category as the
number of SSS cases divided by the number of
person-years at risk in that category. Participants
began accruing time at risk upon their baseline ex-
amination and were followed to the earliest of hos-
pitalization with SSS, death, loss to follow-up, or
December 2009 (ARIC) or June 2008 (CHS).TABLE 2 Incidence Rates of SSS Among Women in ARIC and CHS
Age Group
(yrs)
White Women
SSS
Cases Person-Years
Incidence
(per 1,000) 95%
45–54 1 17,699 0.06 0.00–0
55–64 8 46,164 0.17 0.07–0
65–74 37 50,755 0.73 0.51–1
75–84 61 29,887 2.04 1.56–2
85þ 19 6,428 2.96 1.79–4
CI ¼ conﬁdence interval; SSS ¼ sick sinus syndrome; other abbreviations as in Table 1.We estimated the number of annual incident SSS
cases occurring in the U.S. population age 45 years of
age and older during the period 2012 to 2060, by
applying age-speciﬁc incidence rates from the ARIC
and CHS cohorts to the U.S. Census Bureau populationBlack Women
CI
SSS
Cases Person-Years
Incidence
(per 1,000) 95% CI
.31 1 8,627 0.12 0.00–0.65
.34 2 19,775 0.10 0.01–0.37
.01 10 17,171 0.58 0.28–1.07
.62 16 6,854 2.33 1.43–4.07
.63 5 1,206 4.15 1.35–9.68
TABLE 3 Incidence Rates of SSS Among Men in ARIC and CHS
Age Group
(yrs)
White Men Black Men
SSS
Cases Person-Years
Incidence
(per 1,000) 95% CI
SSS
Cases Person-Years
Incidence
(per 1,000) 95% CI
45–54 1 13,272 0.08 0.00–0.42 0 4,766 0.00 0.00–0.77
55–64 14 38,162 0.37 0.20–0.62 3 10,807 0.28 0.06–0.81
65–74 43 41,075 1.05 0.76–1.41 6 9,411 0.64 0.23–1.39
75–84 47 20,807 2.26 1.66–3.00 2 3,435 0.58 0.07–2.10
85þ 15 3,926 3.82 2.14–6.30 0 399 0.00 0.00–9.25
Abbreviations as in Tables 1 and 2.
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534projections through 2060 (16), and assumed that no
other factors inﬂuenced SSS rates other than changes
in the population age structure. We repeated these
calculations using the lower and upper limits of the
95% conﬁdence intervals (CIs) of the age-speciﬁc rates.
To assess the association between potential risk
factors and incident SSS, we used Cox proportional
hazards models that adjusted for age, sex, race,
clinic, and traditional CV risk factors at baseline
(hypertension, diabetes, smoking, low-density lipo-
protein cholesterol, body mass index [BMI], and
history of a major CV event [myocardial infarction,
heart failure, stroke]). In the ARIC study, models that
included CRP, NT-proBNP, troponin T, and cystatin C
levels were left-truncated at 9 years after baseline,
the point at which these biomarkers were assessed.
For sensitivity analyses, we examined models that
adjusted only for age, sex, race, and clinic, and alsoYear
2020 2030 2040 2050 2060
45-54 55-64TOTAL
65-74 75-84 85+
d Number of Incident SSS Cases per Year, Overall and
d States, 2012 to 2060
esponds to the range of estimates on the basis of the 95% conﬁdence
iﬁc rates. SSS ¼ sick sinus syndrome.models that adjusted for baseline age, sex, race,
and clinic, and traditional CV risk factors as time-
dependent covariates. Continuous risk factors were
scaled to their standard deviations to facilitate
comparisons of hazard ratios (HRs) of risk factors
measured on different scales. High-sensitivity CRP
and NT-proBNP were transformed by log base 2,
because their distributions were right skewed. Cox
proportional hazards models were ﬁt separately for
ARIC and CHS samples; cohort-speciﬁc HRs were
combined using ﬁxed-effects meta-analysis (17).
RESULTS
From among ARIC (N ¼ 15,792) and CHS (N ¼ 5,888)
participants, those who at baseline had evidence of
prevalent SSS, atrial ﬁbrillation, or pacemaker (37 in
ARIC; 385 in CHS), had a heart rate of <50 beats/min
without using beta-blockers (339 in ARIC; 217 in CHS),
or did not report white or black race (101 in ARIC; 29
in CHS) were excluded from the analyses.
Baseline characteristics of the remaining 20,572
participants are reported in Table 1. The average age
of participants was 59 years of age, and 44% were
male. Because of the study design, CHS participants
were older than ARIC participants upon enrollment
(CHS mean age 73 years; ARIC mean age 54 years). As
expected, CHS participants had a higher prevalence
of conditions associated with advanced age,
including hypertension, diabetes, coronary heart
disease, and CKD. Blacks had a higher prevalence of
traditional CV risk factors than whites.
During a mean 17 years of follow-up, 291 incident
SSS cases were identiﬁed, 246 in whites and 45 in
blacks. The crude incidence rate of SSS in ARIC and
CHS was 0.8 (95% CI: 0.7 to 0.9) per 1,000 person-
years. Incidence estimates were similar in ARIC and
CHS (Online Tables 1 and 2). SSS incidence increased
with age and was similar in men and women (Tables 2
and 3). Using the combined ARIC and CHS pop-
ulations as the standard population, the age- and
0.25 0.5 1 2 4 8
Hazard Ratio (95% CI)
Variable*
Age (per 5 yrs)
Male
Black race
BMI (per 5 kg/m2)
Current smoking
Hypertension
Diabetes
LDL-cholesterol (per 40 mg/dl)
CV event**
Height (per 10 cm)
Alcohol use 
HDL-cholesterol (per 20 mg/dl)
CKD
Heart rate (per 6 beats/min)
PR interval (per 30 ms)
QRS interval (per 15 ms)
Right bundle branch block
Left bundle branch block
Cystatin C (per 0.5 mg/l)
CRP (per 2-fold increase)
NT-proBNP (per 2-fold increase)
Troponin T (per ng/l)
3ng/ml
3-5.99ng/ml
6-9.99ng/ml
10ng/ml
HR 95%
Variable*** HR 95%
1.73 1.47 -
1.25 0.73 -
0.59 0.37 -
1.23 1.04 -
1.01 0.60 -
1.56 1.09 -
1.64 0.99 -
0.94 0.78 -
1.24 1.05
CI
2.05
2.50
0.98
1.46
1.72
2.25
2.71
1.14
1.48-
1.00
1.11
0.93
1.76
(REF)
0.59 2.11
1.81
3.37
0.47
0.92
-
-
-
1.17 
2.73
1.42
1.31
1.07
1.45
1.13 
0.69
0.96
1.42 
1.14
0.81 
1.14
0.27
1.15
0.90
1.27
0.93
1.00
0.56
0.64
0.63
0.61 
1.08 
CI
6.57
8.07
1.51
1.26
1.68
1.37
1.38
0.86
1.43
2.17
1.07
1.88
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FIGURE 2 Meta-Analyzed Multivariate Adjusted HRs of Incident SSS According
to Participant Characteristics
The * indicates the results are from 1 multivariate model that includes all of the listed
variables and study clinic as covariates. The ** indicate that the cardiovascular (CV) event
denotes a history of myocardial infarction (MI), heart failure (HF), or stroke at baseline. The
*** indicate that each row represents a separate multivariable model; each model was
adjusted for baseline age, sex, race, study clinic, hypertension, diabetes, body mass index
(BMI), current smoking, low-density lipoprotein (LDL) cholesterol, and history of a CV
event at baseline (MI, HF, or stroke). CI ¼ conﬁdence interval; CKD ¼ chronic kidney
disease; CRP ¼ C-reactive protein; HDL ¼ high-density lipoprotein; HR ¼ hazard ratio;
NT-proBNP ¼ N-terminal pro–B-type natriuretic peptide; SSS ¼ sick sinus syndrome.
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535sex-standardized rate of SSS was 0.9 (95% CI: 0.8 to
1.0) per 1,000 person-years in whites and 0.7 (95% CI:
0.5 to 0.8) per 1,000 person-years in blacks (adjusted
rate ratio 0.75, 95% CI: 0.54 to 1.03, comparing blacks
vs. whites). The age- and race-standardized rate of
SSS was 0.8 (95% CI: 0.7 to 0.9) per 1,000 person-
years in women and 0.9 (95% CI: 0.7 to 1.1) per
1,000 person-years in men (adjusted rate ratio: 1.17,
95% CI: 0.93 to 1.48, comparing men vs. women).
On the basis of ARIC and CHS age-speciﬁc rates of
SSS and U.S. Census Bureau population projections
for the United States between 2012 and 2060, we
estimated that there were approximately 78,000
(95% CI: 57,113 to 99,725) incident cases of SSS in
2012, and that this number would increase to almost
172,000 (95% CI: 127,939 to 216,692) per year by 2060
(Fig. 1). Most of this increment would be caused by an
increased number of SSS events among individuals
age 75 years of age and older.
In models adjusted for age, sex, race, clinic, and CV
risk factors, incident SSS was associated with greater
BMI, height, NT-proBNP, and cystatin C, with longer
QRS interval, with lower heart rate, and with preva-
lent hypertension, right bundle branch block, and
history of a major CV event (Fig. 2). Although male
sex was not associated with incident SSS (HR: 1.25;
95% CI: 0.73 to 2.50), blacks appeared to have a lower
risk of SSS than whites (HR: 0.59; 95% CI: 0.37 to
0.98) after adjustment for age, sex, and CV risk fac-
tors. Results were similar for all risk factors in the
ARIC and CHS cohorts. We found that the use of
minimally adjusted models or models with time-
varying adjustment for traditional CV risk factors
resulted in similar associations between investigated
risk factors and incident SSS (Online Tables 3 and 4).
DISCUSSION
In 2 large, prospective cohorts with an average
follow-up of 17 years, we observed that the inci-
dence of SSS increases with age, does not differ
between men and women, but may be lower among
blacks than whites. The age- and sex-standardized
incidence of SSS was 0.9 per 1,000 person-years in
whites and 0.7 per 1,000 person-years in blacks; after
adjustment for age, sex, and CV risk factors, blacks
had a 41% lower risk of SSS than whites. We identiﬁed
a number of risk factors for SSS, including greater BMI,
height, NT-proBNP level, and cystatin C level, longer
QRS interval, lower heart rate, prevalent hyperten-
sion, and right bundle branch block, and a history of
a CV event at baseline (Central Illustration). This is
the ﬁrst prospective, population-based study, to
our knowledge, to report the incidence of SSS andto investigate risk factors for SSS in the U.S.
population (18).
We estimated that the overall annual incidence
of SSS in individuals age 45 years of age and older
was close to 1 per 1,000. Our rates are consistent
with a previous study of SSS-related hospitalizations
in the Medicare population, which reported age-
speciﬁc hospitalization rates ranging from 0.5 to
3.5 per 1,000 person-years (19). This study by Baine
et al. (19) in the Medicare population, however, did
not differentiate between incident SSS and repeated
hospitalizations, nor did it validate SSS diagnoses.
Even though SSS can occur in the context of well-
deﬁned conditions, such as cardiac amyloidosis
and other cardiomyopathies, or in the context of
ischemic heart disease, most cases of SSS are due
CENTRAL ILLUSTRATION Epidemiology of Sick Sinus Syndrome
Demographic variables, such as increasing age, white race, and cardiovascular risk factors (obesity, hypertension, diabetes) may affect the sinoatrial node promoting
the pathological and electrical substrate of sick sinus syndrome (SSS). Variables in the electrocardiogram (ECG) and blood biomarkers could be used to characterize
the substrate. Eventually, alterations in the sinoatrial node will lead to signs and symptoms of sinus node dysfunction resulting in a clinical diagnosis of SSS.
CV ¼ cardiovascular; NT-proBNP ¼ N-terminal pro–B-type natriuretic peptide; RBBB ¼ right bundle branch block.
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536to degenerative idiopathic ﬁbrotic inﬁltration of the
sinus node (3). Older age and factors associated with
atrial stretch and remodeling, such as hypertension
or heart failure, have been associated with diffuse
atrial ﬁbrosis and electrical remodeling (20–23). The
increased risk of SSS associated with older age,
hypertension, elevated levels of NT-proBNP, and
history of CV disease in the ARIC and CHS cohorts
suggest that atrial ﬁbrosis could speciﬁcally affect
the sinus node and other atrial regions involved in
pacemaker activity. In addition, we observed that
greater height, cystatin C level (a marker of kidney
dysfunction), and white race (vs. black) were asso-
ciated with an elevated risk of SSS. Similar associa-
tions have been described for atrial ﬁbrillation
(24–27). Because atrial ﬁbrillation and SSS fre-
quently coexist—as 1 component of the so-called
“tachy-brady syndrome”—the fact that these 2 con-
ditions share risk factors is not surprising.
Strengths of this study include the large number of
participants in ARIC and CHS, a long duration of
follow-up, validation of most hospitalizations with a
427.81 (SSS) ICD-9-CM code, and detailed and thor-
ough assessment of risk factors. In addition, the risk
factors examined in this analysis were assessed using
similar methodologies in both studies, which enabled
a combining of estimates across cohorts using ﬁxed-
effects models.STUDY LIMITATIONS. First, because SSS is a rare
outcome, we were only able to identify a limited
number of SSS cases, particularly among black par-
ticipants. The available person-time in black men
older than 75 years of age was quite limited. In
addition, it is possible that differential access to
health care by race and sex may have contributed to
the small number of SSS cases identiﬁed in black
men (28). A previous study of Medicare claims also
reported that black men were less likely than white
men to be hospitalized for SSS (19). Second, we were
not able to review medical records for all partici-
pants with an ICD-9 code for SSS. Because we clas-
siﬁed these participants as noncases in the risk
factor analysis, if missing records were unrelated to
the validity of the ICD-9 code, this misclassiﬁcation
likely attenuated associations of risk factors with
SSS. Third, because we relied upon inpatient hos-
pitalization records to identify SSS cases, we may
have missed asymptomatic cases, which were less
severe than those that resulted in an inpatient
hospitalization, or cases diagnosed in an outpatient
setting. Fourth, even though the negative predictive
value of our case ascertainment was excellent
(>97%), some SSS cases were not identiﬁed using
ICD-9 code 427.81. Therefore, our incidence rate
estimates represent a conservative estimate of the
true rate in the general population. Finally, our
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In addition to
age, clinical characteristics associated with sick sinus syndrome
include white race, hypertension, diabetes, obesity, right bundle
branch block, and elevated serum levels of NT-proBNP and
cystatin C.
TRANSLATIONAL OUTLOOK: Further study is needed to
clarify the cellular and biochemical mechanisms that causally
link these risk factors to degenerative ﬁbrotic inﬁltration of
the sinus node and related disease of the cardiac conducting
system, and both elucidate and validate preventive strategies.
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537estimates of new SSS events occurring in the United
States should be interpreted with caution because
they are derived from 2 cohorts that are not repre-
sentative of the entire U.S. population.
No previous studies have examined potential risk
factors for SSS in the general population. Given the
exploratory nature of this analysis, our examination
of a large number of potential risk factors resulted
in multiple comparisons, which may lead to the
appearance of some associations as a result of
chance. However, the directionality and strength of
associations between risk factors and incident SSS
were largely similar in independent ARIC and CHS
models, which decreases the likelihood that these
associations are spurious. Regardless, these ﬁndings
are exploratory in nature; future research is needed
to conﬁrm these associations.
CONCLUSIONS
This study reports that the incidence of SSS increases
with age, and does not differ between men and
women. We also show that the expected number of
SSS diagnoses in the United States will more than
double over the next 50 years. We identiﬁed a
number of risk factors for SSS, including greater BMI,
height, NT-proBNP level, and cystatin C level, longer
QRS interval, lower heart rate, and prevalent hyper-
tension, right bundle branch block, and a history ofa CV event at baseline. Further study is needed to
conﬁrm these ﬁndings and to further explore the
difference in incidence by race.
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